
ABT vs GSK
$ABT vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ABT vs GSK: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Their trends point opposite ways: ABT is above both its 50- and 200-day averages while GSK is below both.
- ·Neither kept up with the market over the past year: ABT -17.6% and GSK +3.5%, against the S&P 500 at +8.8%.
- ·The last month has flipped the order: ABT leads over the month (+3.4% against -4.1%) even though GSK leads over the year.
- ·ABT has support 5.9% below at $97.67; GSK has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
ABT vs GSK: the quick read
- ·ABT is the larger company by market cap ($180.95B vs $98.26B).
- ·ABT has been more active on our scanner (111 vs 74 alerts in 30 days).
- ·ABT has the smaller float (1.72B vs 2.00B), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 111 and 74 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·Both pay a dividend, so this is one of the few pairs here where yield is a fair tiebreaker.
Objective differences only. Not investment advice.
Watching ABT or GSK? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ABT and GSK on TheDesperateTrader.
- Is ABT or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. ABT is the larger company by market cap ($180.95B vs $98.26B). ABT has been more active on our scanner (111 vs 74 alerts in 30 days). ABT has the smaller float (1.72B vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ABT and GSK?
- The differences that matter: they are not in the same business - ABT is pharmaceutical preparations and GSK is pharmaceutical preparations; they are similar in size ($180.95B vs $98.26B); they trade at very different share prices ($103.75 vs $47.74); ABT sits at 44% of its 52-week range against 12% for GSK; our scanner flagged ABT 111 times in the last 30 days against 74 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of ABT and GSK is more active right now?
- Right now ABT is at about 0.8x its normal volume and GSK is at about 0.5x, so ABT is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is ABT or GSK in the stronger trend?
- ABT is above its 50-day average of $103.87 and above its 200-day average of $101.48; GSK is below its 50-day average of $49.32 and below its 200-day average of $52.31. GSK leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ABT or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ABT and GSK comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.